International Alliance for Biological Standardization

Select Page

SCIENTIFIC EVENTS

3Rs implementation in veterinary vaccine batchrelease
testing: Current state-of-the-art and future opportunities

Europe & Americas Webinar
October 6, 2022

3Rs implementation in veterinary vaccine batch-release
testing: Current state-of-the-art and future opportunities

Asia Webinar

October 20, 2022

IABS HPAI Meeting

October 25-26, 2022
Paris, France

8th Annual IABS Statistics Workshop – Advancing the Impact of CMC Statistics for a New Generation of Statisticians, Scientists, and Modelers

November 7-10, 2022

3Rs implementation in veterinary vaccine batch-release testing: Current state-of-the-art and future opportunities
ff
November 16, 2022
Brussels, Belgium

Globally Harmonized Specifications: Current State and Future Opportunities
A Hybrid Meeting

Meeting rescheduled
New Date : January 10-12, 2023

Basel, Switzerland

Maintening the Quality of Vaccines through the Use of References Standards Current Challenges and Future Opportunities

June 21-22, 2023

NEWS

What does IABS do that is unique ?

In this short interview, Joris Vandeputte, President of IABS has answered the question “What does IABS do that is unique ?”
To learn more about the International Alliance for Biological…

Read more

ZAPI Stakeholder Conference Report

We are pleased to let you know that the Zoonoses Anticipation and Preparedness Initiative (ZAPI) Stakeholders Conference Report (February 4 & 5, 2021) is now available.

Report available here

IABS wishes a Happy and Health New Year 2022 to all

IABS wishes a Happy and Health New Year 2022 to all. To learn more about the upcoming conference :

Upcoming events

IABS COLLABORATIONS

INNOVATIVE MEDICINES INITIATIVE (IMI) PROJECTS :

IMI is a European public-private partnership aiming to speed up the development of better and safer medicines. IMI is partly founded by the European Commission.

The IABS European Affiliate (IABS-EU) was part of consortia which have  been selected by IMI to be the public partners of following consortia.

IABS-EU was selected to drive the regulatory part of those consortia.

IABS COLLABORATIONS / MANCO, A EUROPEAN COMMISSION PROJECT :

MANCO (Monclonal Antibodies against COVID-19) is one of the eighteen projects that have been successfully selected by the European Commission, which is devoted to the development of Monoclonal Antibodies agains COVID-19.

IABES-EU was selected to drive the regulatory part of the project

TESTIMONIALS

Paul Henri Lambert

Professor at University of Geneva
Founder of ADVAC

 “I have appreciated the achievements of IABS since many years. It is a unique independent organization that can…

Read more

John Petricciani

Past President
Advisor to the Board

“ Cell substrates have been a key element in the evolution of biological products since the…

Read more

Kathryn Zoon

NIH Scientist Emeritus
Past NIAID Scientific Director

As a long term US regulator and scientist, I have been working with IABS for many years. The IABS has …

Read more

Philippe Duclos

Director ADVAC
University of Geneva

“ A vibrant organization that allows dialogue beyond professional boundaries…

Read more